Variational AI

Variational AI is a pioneering company using advanced generative AI to transform drug discovery. By collaborating with biopharmaceutical partners across diverse disease areas, they work to develop life-changing new therapeutics faster and more efficiently than traditional methods allow. At the heart of their approach is the Enki™ Platform — a commercially accessible foundation model for small molecules, trained on a massive amount of experimental data. What makes Variational AI's approach particularly powerful is the ability to create novel, selective lead structures quickly by defining the Target Product Profile (TPP) upfront, without requiring initial experimental data to get started. This means faster timelines, lower costs, and more precise drug candidates for their partners.